DE10025308A1 - Kombination von Cerivastatin mit ACE Inhibitoren und ihre Verwendung in Arzneimitteln - Google Patents

Kombination von Cerivastatin mit ACE Inhibitoren und ihre Verwendung in Arzneimitteln

Info

Publication number
DE10025308A1
DE10025308A1 DE10025308A DE10025308A DE10025308A1 DE 10025308 A1 DE10025308 A1 DE 10025308A1 DE 10025308 A DE10025308 A DE 10025308A DE 10025308 A DE10025308 A DE 10025308A DE 10025308 A1 DE10025308 A1 DE 10025308A1
Authority
DE
Germany
Prior art keywords
combination
component
cerivastatin
components
ace inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10025308A
Other languages
German (de)
English (en)
Inventor
Gilbert Wagener
Joachim Ippen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE10025308A priority Critical patent/DE10025308A1/de
Priority to PCT/EP2001/005350 priority patent/WO2001089525A1/fr
Priority to AU2001260291A priority patent/AU2001260291A1/en
Publication of DE10025308A1 publication Critical patent/DE10025308A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE10025308A 2000-05-23 2000-05-23 Kombination von Cerivastatin mit ACE Inhibitoren und ihre Verwendung in Arzneimitteln Withdrawn DE10025308A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE10025308A DE10025308A1 (de) 2000-05-23 2000-05-23 Kombination von Cerivastatin mit ACE Inhibitoren und ihre Verwendung in Arzneimitteln
PCT/EP2001/005350 WO2001089525A1 (fr) 2000-05-23 2001-05-10 Combinaison de cerivastatine et d'inhibiteurs de l'enzyme de conversion de l'angiotensine et son utilisation dans des medicaments
AU2001260291A AU2001260291A1 (en) 2000-05-23 2001-05-10 Combination of cerivastatin with ace inhibitors and the use thereof in medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10025308A DE10025308A1 (de) 2000-05-23 2000-05-23 Kombination von Cerivastatin mit ACE Inhibitoren und ihre Verwendung in Arzneimitteln

Publications (1)

Publication Number Publication Date
DE10025308A1 true DE10025308A1 (de) 2001-11-29

Family

ID=7643122

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10025308A Withdrawn DE10025308A1 (de) 2000-05-23 2000-05-23 Kombination von Cerivastatin mit ACE Inhibitoren und ihre Verwendung in Arzneimitteln

Country Status (3)

Country Link
AU (1) AU2001260291A1 (fr)
DE (1) DE10025308A1 (fr)
WO (1) WO2001089525A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092729A1 (fr) * 2002-05-03 2003-11-13 Hexal Ag Formulation pharmaceutique stable contenant une statine combinee avec un inhibiteur de l'ace
WO2004080488A2 (fr) * 2003-03-10 2004-09-23 Bayer Healthcare Ag Preparations combinees d'acide acetylsalycilique pour la prevention primaire de maladies cardiovasculaires

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
GB0001662D0 (en) * 1999-02-06 2000-03-15 Zeneca Ltd Pharmaceutical compositions

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092729A1 (fr) * 2002-05-03 2003-11-13 Hexal Ag Formulation pharmaceutique stable contenant une statine combinee avec un inhibiteur de l'ace
WO2004080488A2 (fr) * 2003-03-10 2004-09-23 Bayer Healthcare Ag Preparations combinees d'acide acetylsalycilique pour la prevention primaire de maladies cardiovasculaires
WO2004080488A3 (fr) * 2003-03-10 2005-05-06 Bayer Healthcare Ag Preparations combinees d'acide acetylsalycilique pour la prevention primaire de maladies cardiovasculaires

Also Published As

Publication number Publication date
AU2001260291A1 (en) 2001-12-03
WO2001089525A1 (fr) 2001-11-29

Similar Documents

Publication Publication Date Title
DE60000133T2 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
DE60320652T2 (de) Zusammensetzung frei von ascorbicsäure enthaltend einen hemmer der cholesterinabsorption, einen hemmer der hmg-coa reduktase und ein stabilisierungsmittel
CN102743755B (zh) 预防中风复发的组合物
CN101217952A (zh) 用于预防心血管事件发病的组合物
DE3627423A1 (de) Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
DE3705549A1 (de) Verwendung von pyridoxin-derivaten bei der prophylaxe und therapie von hyperlipidaemien und atherosklerose
DE19858789A1 (de) Kombination von Cerivastatin und Fibraten
US20040014712A1 (en) Blood lipid ameliorant composition
WO2004080488A2 (fr) Preparations combinees d'acide acetylsalycilique pour la prevention primaire de maladies cardiovasculaires
DE19929065A1 (de) Kombination von MTP-Inhibitoren und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
EP1937253B1 (fr) Association medicamenteuse de sels de l'acide o-acetylsalicylique
DE10025308A1 (de) Kombination von Cerivastatin mit ACE Inhibitoren und ihre Verwendung in Arzneimitteln
EP1001756B1 (fr) Compositions a effet synergique pour lutter selectivement contre les tissus tumoraux
DE19929031A1 (de) Kombination von MTP-Inhibitoren und Lipidsenkern und ihre Verwendung in Arzneimitteln
US7037934B2 (en) Blood lipid ameliorant composition
DE19944803A1 (de) Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
US20030220343A1 (en) Compositions for improving lipid content in the blood
DE10351648A1 (de) Kombinationspräparate von Acetylsalicylsäure zur primären Prävention von Herzkreislauferkrankungen
DE19929012A1 (de) Kombination von MTP-Inhibitoren und stoffwechselbeeinflussenden Wirkstoffen und ihre Verwendung in Arzneimitteln
WO2004105771A1 (fr) Association d'acide acetylsalicylique et d'inhibiteurs de l'alpha-glucosidase
DE60124400T2 (de) Verwendung eines betablockers zur behandlung von atherosklerose
DE69011692T2 (de) Therapeutische mittel.
WO1995028924A1 (fr) PREPARATIONS COMBINEES CONTENANT UN DERIVE D'ACIDE p-OXYBENZOÏQUE, PAR EXEMPLE DU LIFIBROL, ET UN INHIBITEUR DE LA HMG-CoA-REDUCTASE TEL QUE LA LOVASTATINE, LA PRAVASTATINE OU LA SIMVASTATINE
MXPA01006136A (en) Combination of cerivastatin and fibrates
WO1995028919A1 (fr) MEDICAMENT CONTENANT UN DERIVE D'ACIDE p-OXYBENZOIQUE ET UN FIBRATE

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee